Is Keflex (cefalexin) a suitable treatment option for an adult male patient with an uncomplicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) for Male UTI

Keflex is NOT a first-line agent for male UTIs and should only be used when preferred antibiotics cannot be used, with treatment extended to 14 days since male UTIs are classified as complicated infections that often involve the prostate. 1, 2

Why Male UTIs Require Different Treatment

  • All UTIs in men are considered complicated infections due to anatomical and physiological factors, requiring longer treatment duration and broader consideration of resistant pathogens compared to uncomplicated cystitis in women. 1, 2
  • The microbial spectrum is broader in male UTIs, with increased likelihood of antimicrobial resistance including E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., and Enterococcus spp. 1
  • Prostatitis cannot be excluded in most initial presentations, necessitating 14-day treatment courses rather than shorter durations. 1, 2

Preferred First-Line Agents (NOT Cephalexin)

  • Trimethoprim-sulfamethoxazole for 14 days is the recommended first-line oral agent for male UTIs. 2
  • Fluoroquinolones (ciprofloxacin or levofloxacin) for 14 days may be used when local resistance is <10%, the patient hasn't used them in the past 6 months, and beta-lactam alternatives cannot be used. 1, 2
  • Oral cephalosporins like cefpodoxime (200 mg twice daily for 10 days) or ceftibuten (400 mg once daily for 10 days) are preferred over cephalexin when TMP-SMX cannot be used. 2

When Cephalexin May Be Considered

  • Beta-lactams including cephalexin are classified as alternative agents with inferior efficacy compared to first-line options for UTIs. 3
  • Cephalexin should only be used when culture-directed therapy demonstrates susceptibility and preferred agents cannot be used. 2
  • If cephalexin must be used, prescribe 500 mg twice daily for 14 days (not the traditional four times daily dosing), as recent evidence shows twice-daily dosing is equally effective with better adherence. 4, 5, 6

Critical Management Steps

  • Obtain urine culture and susceptibility testing BEFORE initiating antibiotics to guide potential therapy adjustments. 1, 2
  • Perform digital rectal examination to evaluate for prostate involvement. 3
  • Evaluate for underlying urological abnormalities such as obstruction, incomplete voiding, or structural abnormalities that may contribute to infection. 1, 2

Treatment Duration Considerations

  • Standard duration is 14 days when prostatitis cannot be excluded, which applies to most male UTI presentations. 1, 2
  • A shorter 7-day course may only be considered if the patient becomes afebrile within 48 hours with clear clinical improvement, though recent evidence shows 7-day ciprofloxacin was inferior to 14-day treatment in men (86% vs 98% cure rate). 1, 2

Common Pitfalls to Avoid

  • Failing to obtain pre-treatment urine cultures complicates management if empiric therapy fails. 2
  • Using inadequate treatment duration (less than 14 days) leads to persistent or recurrent infection, particularly when prostate involvement is present. 2
  • Prescribing cephalexin as first-line empirically when better-studied agents with superior efficacy are available. 3, 2
  • Ignoring the possibility of multidrug-resistant organisms, which are more common in male UTIs and may require alternative agents like ceftazidime-avibactam or carbapenems. 2

Evidence Quality Note

While older studies from the 1980s-2000s demonstrate cephalexin's efficacy in UTIs generally 7, 8, modern guidelines prioritize other agents based on superior efficacy data and the recognition that male UTIs represent complicated infections requiring more robust treatment approaches. 3, 1, 2

References

Guideline

Treatment of Male Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Treatment for Urinary Tract Infections in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.